BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10206028)

  • 1. [Antithrombin III in intensive therapy].
    Baudo F; Caimi TM; Decataldo F; Calori G
    Minerva Anestesiol; 1999; 65(1-2 Suppl 1):71-6. PubMed ID: 10206028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 4. Epilogue: disseminated intravascular coagulation and antithrombin III in intensive care medicine: pathophysiological insights and therapeutic hopes.
    Schuster HP
    Semin Thromb Hemost; 1998; 24(1):81-3. PubMed ID: 9515783
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

  • 6. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T; Thachil J
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study.
    Kreuz WD; Schneider W; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are there certified indications for the use of antithrombin III in intensive care].
    Kulka PJ; Tryba M; Lange S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III and sepsis.
    Mammen EF
    Intensive Care Med; 1998 Jul; 24(7):649-50. PubMed ID: 9722032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired antithrombin deficiency in sepsis.
    White B; Perry D
    Br J Haematol; 2001 Jan; 112(1):26-31. PubMed ID: 11167778
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III replacement in animal models of acquired antithrombin III deficiency.
    Emerson TE
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical use of antithrombin III concentrates.
    Vinazzer H
    Vox Sang; 1987; 53(4):193-8. PubMed ID: 3326267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiology, clinical significance and therapy of antithrombin III deficiencies].
    Lechner K; Thaler E; Niessner H
    Acta Med Austriaca; 1983; 10(5):129-35. PubMed ID: 6666509
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
    Kobayashi H; Kawai S; Oshitani H; Tamakuma S; Hayasaka H; Akiyama M; Nakamura T; Hashimoto I; Sawada Y; Takebe K
    Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.